Emergent BioSolutions Completes Acquisition of Sanofi’s Small-Pox Vaccine Business
By
Emergent BioSolutions, a specialty biopharmaceutical company and contract manufacturer, has completed its previously announced $117-million acquisition of Sanofi’s smallpox vaccine business, which includes ACAM2000 (a smallpox vaccine), two US manufacturing…